ACADIA Pharmaceuticals In... (ACAD)
NASDAQ: ACAD
· Real-Time Price · USD
21.57
-0.72 (-3.23%)
At close: May 30, 2025, 3:59 PM
21.17
-1.87%
After-hours: May 30, 2025, 05:44 PM EDT
-3.23% (1D)
| Bid | 20.74 |
| Market Cap | 3.61B |
| Revenue (ttm) | 996.28M |
| Net Income (ttm) | 228.88M |
| EPS (ttm) | 1.39 |
| PE Ratio (ttm) | 15.52 |
| Forward PE | 25.92 |
| Analyst | Buy |
| Ask | 22.6 |
| Volume | 1,040,470 |
| Avg. Volume (20D) | 2,101,259 |
| Open | 22.30 |
| Previous Close | 22.29 |
| Day's Range | 21.55 - 22.25 |
| 52-Week Range | 13.40 - 25.23 |
| Beta | 0.47 |
About ACAD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACAD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACAD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+26.48%
ACADIA Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
3 weeks ago
+14.31%
ACADIA Pharmaceuticals shares are trading higher after the company reported better-than-expected Q1 financial results.
2 weeks ago · seekingalpha.com
Acadia Pharmaceuticals: Another Legal Win, ACP-101 Readout PreviewAcadia Pharmaceuticals secured another court win on Nuplazid that solidifies its IP position and long-term exclusivity. The commercial business' performance remains slightly underwhelming but there ar...
